Search

everythinglearnresearchcommunity

for

Search:↓

Epigenetic factors affect the success of using iPSC-derived cells for spinal cord injury treatment.

SPARC-modified stem cells significantly improve dog skin wound healing.

Mesotherapy can be beneficial but has risks if misused.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

A natural extract-based hair growth product was developed and showed promise in preliminary tests.

PBX1 reduces aging and cell death in stem cells by boosting SIRT1 and lowering PARP1.

The oral supplement with Pinus pinaster and Grape seed extract, used with sunscreen, effectively and safely improved mild-to-moderate facial melasma.

Mesenchymal stem cells and their secretions might help treat chronic skin inflammation in atopic dermatitis.

The treatment slightly increased hair growth and was safe for most women.

A new microneedle treatment could effectively regrow hair in androgenic alopecia.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

Regenerative dentistry using stem cells shows promise for healing and rebuilding tissues.

Some synthesized peptides improved cell growth better than thymosin β4, VEGF, and minoxidil.

Organoids created from stem cells are used to model diseases, test drugs, and develop personalized and regenerative medicine.

ThriveCo Anti-Dandruff Pre-Shampoo Treatment effectively reduces dandruff and improves scalp health without side effects.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

These new skin treatments are safer and more effective with minimal side effects.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

Drug repurposing shows promise for treating many medical conditions.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

The material combining eggshell protein and scaffold helps wounds heal faster and regenerates tissue effectively.